Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Alopecia areata in infants may be more common than previously thought.

Most patients with small patches of hair loss usually regrow hair.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

Superficial cryotherapy is effective and safe for treating alopecia areata, especially eyebrow hair loss.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

The four main causes of hair loss in children are fungal infections, pulling out hair, autoimmune hair loss, and stress-related hair shedding.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Most lupus patients in the study experienced hair loss, which greatly affected their mental and social well-being.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.